Neudle.com: antipsychotic drug

Differential
(Click to cross reference)

acetylcholine

advances in neurology

adverse drug reaction

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, treatment of

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, enzyme inducing

anticonvulsants, untoward effects of

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

azidodeoxythymidine

behavior

behavior modification

behavior, combative

behavioral disorder

benzodiazepine

beta adrenergic blocker

calcium antagonist, side effects of

carbamazepine

caregiver

CAT scan, emission, abnormal

catatonia

catatonia, lethal

cerebral cortical atrophy

cerebrovascular accident

cerebrovascular accident, prevention of

cingulate island sign

citalopram

Clinical Pathologic Conference(C.P.C.)

confusional state, acute

congestive heart failure

cooling therapy

coprolalia

counselling

creatine phosphokinase(CPK)elevated

critical care unit

cultured skin fibroblasts

delirium, work up for

delusion

dementia

dementia, clinical diagnosis

dementia, prevention of

dementia, treatment of

differential diagnosis

dopamine depleting agents

drug abuse

drug induced neurologic disorders

drug interactions

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dysphagia

dyspnea

dystonia

dystonia, drug induced

dystonia, face

dystonia, treatment of

dystonia, truncal

dystonic reaction, acute

echolalia

efficacy

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

emergencies, medical

emergencies, neurologic

epidemiology of neurology

ergotamine

evidence-based research

exercise

extrapyramidal

facial movement disorder

falling

fatigue

fever

fibrinolytic agents, utilization

genetic neurologic disorders

Gilles de la Tourette syndrome

grunting

guanfacine

hallucination

hallucination, visual

headache, intractable

headache, severe

headache, treatment of

heatstroke

hemiballismus

heralding manifestation

hyperammonemic encephalopathy

hypotension, systemic

iatrogenic neurologic disorders

impulsivity

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inappropriate behavior

inattention

inclusion bodies

insomnia

intellectual deterioration

interobserver agreement

jealousy

L-dopa

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

lethargy

leukocytosis

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

lithium

liver function enzymes

lorazepam

malignant hyperpyrexia

marihuana

medical-legal aspects of neurology

medication withdrawal

mellaril

memantine

mental retardation

mental status, abnormal

migraine, intractable

migraine, treatment of

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

neuroleptic induced catatonia

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurological intensive care

neuromuscular blockade

neuropathology

neuropathology, brain

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

nortriptyline

nursing home

obesity

obsessive-compulsive disorder

olanzapine

old age, neurology of

ondansetron

oral contraceptives

orthostatic hypotension

parietal lobe, atrophy

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, fluctuations in

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, wearing off

Parkinsonism hyperpyrexia syndrome

Parkinsonism syndrome

paroxetine

patient information and support

penicillamine

phenothiazine

phenothiazine, dyskinesia associated with

physostigmine

pimozide

pimozide, side effects

Pisa syndrome

placebo

poison, neurologic problems with

posterior cortical atrophy

postoperative neurologic complications

postural abnormality

practice guidelines

premarin

prevention of neurologic disorders

procainamide

progesterone

prognosis

progressive neurologic disorder

propranolol

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

REM sleep behavior disorder

renal failure

renal failure, acute

repetitive questioning

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

respiratory failure

respiratory myoclonus

restless leg syndrome

risk-benefit assessment

risperidone

rummaging

safety

salivation, excessive

schizophrenia

sedation

seizure

seizure, drug-induced

selective serotonin reuptake inhibitors

sleep pathology and physiology

sodium valproate, intravenous

stimulation, deep brain

tardive diaphragmatic flutter

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tic, chronic multiple

tic, classification of

tranquilizers, neurologic complications with

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

tremor

tremor, jaw

tremor, treatment of

tricyclic antidepressant

trifluoperazine

triptans

undiagnosed

urine osmolality, elevated

wandering

weight gain

Showing articles 50 to 100 of 6670 << Previous Next >>

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998

Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998

Tourette Syndrome:Update and Review of the Literature
The Neurologist 4:188-195, Feigin,A.&Clarke,H., 1998

Clozapine in Parkinson's Disase Tremor, Effets of Acute and Chronic Administration
Neurol 49:1587-1590, Bonuccelli,U.,et al, 1997

Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997

Olanzapine:A Novel Atypical Neuroleptic Agent
Lancet 349:1264-1265, Reus,V.I., 1997

Benztropine vs Clozapine for the Treatment of Tremor in Parkinson's Disease
Neurol 48:1077-1081, Friedman,J.H.,et al, 1997

Low-Dose Clozapine Improves Dyskinesias in Parkinson's Disease
Neurol 48:658-662, Durif,F.,et al, 1997

Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Consensus Guidelines for Clin & Path Dx of Dementia with Lewy Bodies (DLB) :Report of DLB Intl Workshop
Neurol 47:1113-1114, 11241996., McKeith,I.G.,et al, 1996

Clozapine-Induced Myotoxicity in Patients with Chronic Psychotic Disorders
Neurol 47:1518-1523, Scelsa,S.N.,et al, 1996

Oral and Genital Pain Syndromes in Parkinson's Disease
Movement Disorders 11:421-426, Ford,B.,et al, 1996

Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995

Neuroleptic Malignant Syndrome
JNNP 58:271-273, Buckley,P.F.&Hutchinson,M., 1995

Resperidone in Gilles de la Tourette Syndrome
Neurol 45:1419, Shulman,L.M.,et al, 1995

Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995

Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994

Clinical Assessment of Extrapyramidal Signs in Nursing Home Patients Given Antipsychotic Medication
Arch Int Med 154:1113-1117, Avorn,J.,et al, 1994

Clozapine-Related Seizures:Experience with 5, 629 Patients
Neurol 44:2247-2249, Pacia,S.V.&Devinsky,O., 1994

Clozapine:A 2-year Open Trial in Parkinson's Disease Patients with Psychosis
Neurol 44:544-546, Factor,S.A.,et al, 1994

Clozapine in Huntington's Chorea
Neurol 44:821-823, Bonuccelli,U.,et al, 1994

An Eval of the Predictive Validity & Inter-Rater Reliability of Diagnostic Crit for Senile Dementia of Lewy Body Type
Neurol 44:872-877, McKeith,I.G.,et al, 1994

Risperidone
Lancet 343:457-460, Livingston,M.G., 1994

Hyperthermia and Heatstroke
Hospital Practice 29:65-68, 73, 78-80994., Simon,H.B., 1994

How"Malignant"is the Neuroleptic Malignant Syndrome
BMJ 307:1223-1224, Bristow,M.F.&Kohen,D., 1993

Psychotropic Drugs and Sleep
BMJ 306:1331-1334, Eisen,J.,et al, 1993

Neuroleptics, Learning Disability, and the Community:Some History and Mystery
BMJ 307:184-187, Manchester,D., 1993

Tardive Dyskinesia Presenting as Severe Dysphagia
JNNP 55:1203-1204, Gregory,R.P.,et al, 1992

Neuroleptic Sensitivity in Patients with Senile Dementia of Lewy Body Type
BMJ 305:673-678, McKeith,J.,et al, 1992

Unsuspected, Surreptitious Drug-Induced Parkinsonism
Neurol 42:459, Albanese,A.,et al, 1992

Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992

Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Neuroleptic-Induced Catatonia as a Stage in the Progression Toward NMS
J Am Acad Child Adolesc Psychiatry 31:1161-1164, Woodbury,M.M.&Woodbury,M.A., 1992

Clozapine is Beneficial for Psychosis in Parkinson's Disease
NEurol 41:1699-1700, Kahn,N.,et al, 1991

Prospective Study of Tardvie Dyskinesia Incidence in the Elderly
JAMA 266:2402-2406, Saltz,B.L.,et al, 1991

Clozapine, A Novel Antipsychotic Agent
NEJM 324:746-754, Baldessarini,R.J.&Frankenburg,F.R., 1991

Clozapine-Related Seizures
Neurol 41:369-371, Devinsky,O.,et al, 1991

Clozapine in the Treatment of Parkinsonian Patients with Dopaminomimetic Psychosis
Neurol 40:832-834, Wolters,E.Ch.,et al, 1990

Adult Sphingomyelinase Deficiency:Report of 2 Patients who Initially Presented with Psychiatric Disorders
Neurol 40:132-136, Dubois,G.,et al, 1990

Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990

Clozapine in the Treatment of Psychosis in Parkinson's Disease
Neurol 39:1219-1221, Friedman,J.H.&Lannon,M.C., 1989

Showing articles 50 to 100 of 6670 << Previous Next >>